Prognostic and Predictive Value of p21-activated Kinase 6 Associated Support Vector Machine Classifier in Gastric Cancer Treated by 5-fluorouracil/Oxaliplatin Chemotherapy
Open Access
- 1 August 2017
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 22, 78-88
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Upregulated Expression of C-X-C Chemokine Receptor 4 Is an Independent Prognostic Predictor for Patients with Gastric CancerPLOS ONE, 2013
- Eight-Signature Classifier for Prediction of Nasopharyngeal Carcinoma SurvivalJournal of Clinical Oncology, 2011
- Expression of p21WAF1 in Astler–Coller stage B2 colorectal cancer is associated with survival benefit from 5FU-based adjuvant chemotherapyVirchows Archiv, 2011
- Ki67 in breast cancer: prognostic and predictive potentialThe Lancet Oncology, 2010
- Inhibition of p21‐activated kinase 6 (PAK6) increases radiosensitivity of prostate cancer cellsThe Prostate, 2010
- Systemic treatment of gastric cancerCritical Reviews in Oncology/Hematology, 2009
- Three Immunomarker Support Vector Machines–Based Prognostic Classifiers for Stage IB Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2009
- Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markersBMC Medical Informatics and Decision Making, 2008
- Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteinsThe Prostate, 2008
- An overview of statistical learning theoryIEEE Transactions on Neural Networks, 1999